Genesis Centre for Fertility & Human Pre-Implantation Genetics is a dedicated fertility institution that has provided human reproduction treatments for over 25 years. It is the first establishment to have acquired European Union tissue directive clearance in Cyprus, Greece, the Eastern and Central European Union countries. This means that Genesis complies with all prerequisites set by the guidelines of the EU in relation to standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Genesis has in this respect been granted licence to undertake any type of clinical and/or laboratory fertility intervention available to humans to date.
Genesis is the only fertility establishment which offers a money back guarantee programme for all IVF mediated treatment modalities known today.
The founder and scientific director of the clinic is Dr Savvas Koundouros, an accredited clinical embryologist with more than 28 years’ experience in the field of assisted human reproduction. He is a British graduate (University of Birmingham) and has specialised in clinical science at King’s College Hospital in London. Dr Koundouros completed a PhD related to polycystic ovarian syndrome manifestation with academic publications in this field and a second PhD in Y chromosome gamete enrichment techniques at the Monash University Institute of Medical Research in Melbourne Australia. He has substantial experience in the field of human embryo pre-implantation genetic diagnosis having performed possibly the most embryo biopsies and subsequent diagnoses worldwide. It is estimated that more than 75,000 embryos have been biopsied and diagnosed to date.
The Genesis team is comprised of specialist gynaecologists and clinical scientists most of whom have graduated from UK medical schools.
Intrauterine Insemination (IUI)
IUI is in essence the direct injection of spermatozoa into the inner cavity of the uterus (endometrium) and aims at increasing the number of sperm that enter the fallopian tubes therefore improving the chances of egg fertilisation.
In Vitro Fertilisation (IVF)
IVF entails the removal of eggs from the ovaries of a female, their fertilisation under precise environmental conditions and the replacement of one or more embryos back into the uterus.
This treatment modality can be recommended to women who mature very poor-quality eggs, too few eggs or eggs which are abnormal due to genetic reasons. Genesis has a dedicated team of accredited professionals who provide continuous support and individualised care to patient/couples.
Pre-Implantation Genetic Diagnosis (PGD)
PGD is offered to couples who are at risk passing on an inherited disorder to their offspring. Couples who present such genetic predispositions may opt to benefit from the advances in PGD technology to eliminate the risk which may lead to a miscarriage or a potential elective termination or transition the condition to their offspring.
New Generation Sequence (NGS)
NGS (New generation Sequencing) is a new, cutting-edge technology which can analyse small quantities of DNA extracted from day 5 embryos and generate a comprehensive analysis of all 24 chromosomes with remarkable resolution and sensitivity. The implantation potential of embryos which have been found healthy for all chromosomes following NGS analysis is as high as 80% following successful thawing.
Cryopreservation of embryos which resulted as surplus from an IVF cycle allows couples to pursue subsequent frozen/thawed embryo replacement(s).
Sperm/Egg Freezing & Fertility preservation
Sperm/egg freezing and preservation has enormous potential in reproduction medicine mainly in terms of deferring childbearing until later in life for personal (eg pursuing a career) or medical reasons (use of chemotherapeutic drugs and pelvic radiotherapy for cancer).
Address: 45 Thessaloniis /street, Kyriakos Court, 4th Floor Limassol 3025
Email: [email protected]
Tel: 25 878727
THE ADVERTORIAL WAS PUBLISHED IN THE CYPRUS MAIL’S ‘HEALTHCARE GUIDE’ MAGAZINE (11/2018)